Alpha Innotech Corp. - Financial and Strategic Analysis Review

Alpha Innotech Corp. - Financial and Strategic Analysis Review

Summary

Global Markets Direct’s “Alpha Innotech Corp. - Financial and Strategic Analysis Review” is an in-depth business, strategic and financial analysis of Alpha Innotech Corp. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Alpha Innotech Corporation (Alpha CA) is engaged in manufacturing and marketing laboratory analytical instruments, software, and consumables for life science research laboratories. It is a wholly owned subsidiary of Xtrana, Inc. The company offers high quality imaging and medical equipments products by combining various instruments to create an integrated modular technology platform. Its customer base includes pharmaceutical and biotechnology companies, universities, medical centers, government institutions for researches and research agencies all over the world.

Recent Developments

Sep 08, 2009: Cell Biosciences Enters Agreement To Acquire Alpha Innotech
Aug 05, 2009: Alpha Innotech Reports Revenues Of $4.25 Million In Q2 2009
Jun 30, 2009: Alpha Innotech Elects Chris van Ingen And Shahram Hejazi To Its Board

Scope

• Provides key company information for business intelligence needs
• The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick “one-stop-shop” to understand the company.
• Enhance business/sales activities by understanding customers’ businesses better.
• Get detailed information and financial & strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitors’ weaknesses and target the market opportunities available to them.
• Compare your company’s financial trends with those of your peers / competitors.
• Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.